* Prostate Cancer in Japan: We conducted clinical trials to develop more effective REIC formulation. Currently we have completed Phase II clinical trial.
* Malignant mesothelioma in US: The Phase I study in US was skipped because it has been completed in Japan.

As of July 1, 2023